Additionally, tumor-specific CD8+ T lymphocytes often co-express PD-1 and BTLA, with BTLA+PD-1+ cells displaying greater dysfunction, including reduced IFN-γ production compared to BTLA−PD-1+ cells [52]. This evidence concerns the gene BTLA and neoplasm.